Use of Programmed Death Receptor-1 and/or Programmed Death Ligand 1 Inhibitors for the Treatment of Brain Metastasis of Lung Cancer

MLA

Wang,Shiqiang, et al. “Use of Programmed Death Receptor-1 and/or Programmed Death Ligand 1 Inhibitors for the Treatment of Brain Metastasis of Lung Cancer.” OncoTargets and Therapy, Jan. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dovemedicalp..88df5c0d0ecc51e0ce6b4847d69e885c&authtype=sso&custid=ns315887.

APA

Wang,Shiqiang, Hu,Chongling, Xie,Fei, & Liu,Yanhui. (2020). Use of Programmed Death Receptor-1 and/or Programmed Death Ligand 1 Inhibitors for the Treatment of Brain Metastasis of Lung Cancer. OncoTargets and Therapy.

Chicago

Wang,Shiqiang, Hu,Chongling, Xie,Fei, and Liu,Yanhui. 2020. “Use of Programmed Death Receptor-1 and/or Programmed Death Ligand 1 Inhibitors for the Treatment of Brain Metastasis of Lung Cancer.” OncoTargets and Therapy, January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dovemedicalp..88df5c0d0ecc51e0ce6b4847d69e885c&authtype=sso&custid=ns315887.